In particular, the disease development is primarily caused by the somatic KIT p.D816 V mutation, with additional mutations in such genes as TET2, SRSF2, and ASXL1 contributing to advanced disease forms (e.g., ASM, SM‐AHN). The gene discussed is SRSF2; the disease is systemic mastocytosis.